Literature DB >> 17671792

Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells.

Li Wang1, Xuerui Zhou, Tingting Zhou, Dong Ma, Sifeng Chen, Xiuling Zhi, Lianhua Yin, Zhimin Shao, Zhouluo Ou, Ping Zhou.   

Abstract

PURPOSE: Associated with many molecules, metastasis includes cell adhesion to extracellular matrix, migration towards specific direction and invasion into local vessel of distant organs. The purpose of the present study was to evaluate the role of ecto-5'-nucleotidase (eN, ecto-5-NT, CD73) generated extracellular adenosine in biologically malignant behaviors of human breast cancer cell lines.
MATERIALS AND METHODS: Two human breast cancer cell lines, T-47D with lower expression of CD73 and MB-MDA-231 with higher expression of CD73, were used to investigate the functions of CD73. The effects of CD73 over-expression on invasion, migration and adhesion were observed in T-47D transfected with pcDNA-NT5E plasmid. The effects of specific CD73 inhibitor, alpha, ss-methylene ADP (APCP), were observed in MB-MDA-231 cells.
RESULTS: The results showed CD-73 overexpression increased invasion, migration and adhesion to ECM of the pcDNA-NT5E transfected T-47D cells compared to the saline and mock vector controls. The increased cell mobility of CD-73-overexpressed T-47D cells was blocked by APCP. Adenosine increased the mobility of wild type T-47D cells. APCP inhibited the mobility of the MB-MDA-231 cells.
CONCLUSION: Taken together, our results indicated that CD73 may facilitate the adhesion, migration and invasion of human breast cancer cells through its enzyme activity of generating adenosine. This study provided a possibly molecular mechanism of metastasis of breast carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671792     DOI: 10.1007/s00432-007-0292-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  54 in total

1.  Adenosine receptor mediates motility in human melanoma cells.

Authors:  E C Woodhouse; D F Amanatullah; J A Schetz; L A Liotta; M L Stracke; T Clair
Journal:  Biochem Biophys Res Commun       Date:  1998-05-29       Impact factor: 3.575

2.  Evidence for the direct interaction of chicken gizzard 5'-nucleotidase with laminin and fibronectin.

Authors:  U Stochaj; J Dieckhoff; J Mollenhauer; M Cramer; H G Mannherz
Journal:  Biochim Biophys Acta       Date:  1989-09-15

3.  Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells.

Authors:  L Kamath; A Meydani; F Foss; A Kuliopulos
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

4.  Ecto-5'-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin.

Authors:  P Ujházy; M Klobusická; O Babusíková; P Strausbauch; E Mihich; M J Ehrke
Journal:  Int J Cancer       Date:  1994-10-01       Impact factor: 7.396

5.  Adenosine prevents permeability increase in oxidant-injured endothelial monolayers.

Authors:  L F Richard; T E Dahms; R O Webster
Journal:  Am J Physiol       Date:  1998-01

6.  Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistance.

Authors:  P Ujházy; E S Berleth; J M Pietkiewicz; H Kitano; J R Skaar; M J Ehrke; E Mihich
Journal:  Int J Cancer       Date:  1996-11-15       Impact factor: 7.396

7.  Molecular classification of human carcinomas by use of gene expression signatures.

Authors:  A I Su; J B Welsh; L M Sapinoso; S G Kern; P Dimitrov; H Lapp; P G Schultz; S M Powell; C A Moskaluk; H F Frierson; G M Hampton
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

8.  Adenosine stimulation of proliferation of breast carcinoma cell lines: evaluation of the [3H]thymidine assay system and modulatory effects of the cellular microenvironment in vitro.

Authors:  Michelle Mujoomdar; Amy Bennett; David Hoskin; Jonathan Blay
Journal:  J Cell Physiol       Date:  2004-12       Impact factor: 6.384

9.  Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.

Authors:  E W Thompson; S Paik; N Brünner; C L Sommers; G Zugmaier; R Clarke; T B Shima; J Torri; S Donahue; M E Lippman
Journal:  J Cell Physiol       Date:  1992-03       Impact factor: 6.384

10.  CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73.

Authors:  L Airas; J Hellman; M Salmi; P Bono; T Puurunen; D J Smith; S Jalkanen
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  79 in total

Review 1.  New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors.

Authors:  Ross Corriden; Paul A Insel
Journal:  Purinergic Signal       Date:  2012-04-15       Impact factor: 3.765

2.  CD73 promotes tumor growth and metastasis.

Authors:  Bin Zhang
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

3.  Conditioned Medium from Adipose-Derived Stem Cells (ADSCs) Promotes Epithelial-to-Mesenchymal-Like Transition (EMT-Like) in Glioma Cells In vitro.

Authors:  Isabele C Iser; Stefanie M Ceschini; Giovana R Onzi; Ana Paula S Bertoni; Guido Lenz; Márcia R Wink
Journal:  Mol Neurobiol       Date:  2015-12-19       Impact factor: 5.590

4.  An adenosine-mediated signaling pathway suppresses prenylation of the GTPase Rap1B and promotes cell scattering.

Authors:  Elizabeth Ntantie; Patrick Gonyo; Ellen L Lorimer; Andrew D Hauser; Nathan Schuld; Donna McAllister; Balaraman Kalyanaraman; Michael B Dwinell; John A Auchampach; Carol L Williams
Journal:  Sci Signal       Date:  2013-05-28       Impact factor: 8.192

5.  Adenosine arrests breast cancer cell motility by A3 receptor stimulation.

Authors:  Carola Ledderose; Marco M Hefti; Yu Chen; Yi Bao; Thomas Seier; Linglin Li; Tobias Woehrle; Jingping Zhang; Wolfgang G Junger
Journal:  Purinergic Signal       Date:  2016-08-30       Impact factor: 3.765

6.  Functional analysis of LOXL2 in pancreatic carcinoma.

Authors:  Felix Rückert; Peer Joensson; Hans-Detlev Saeger; Robert Grützmann; Christian Pilarsky
Journal:  Int J Colorectal Dis       Date:  2009-12-09       Impact factor: 2.571

7.  Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.

Authors:  John Stagg; Upulie Divisekera; Nicole McLaughlin; Janelle Sharkey; Sandra Pommey; Delphine Denoyer; Karen M Dwyer; Mark J Smyth
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

Review 8.  Induced regulatory T cells in inhibitory microenvironments created by cancer.

Authors:  Theresa L Whiteside
Journal:  Expert Opin Biol Ther       Date:  2014-06-17       Impact factor: 4.388

9.  NTPDase3 and ecto-5'-nucleotidase/CD73 are differentially expressed during mouse bladder cancer progression.

Authors:  Liliana Rockenbach; Elizandra Braganhol; Fabrícia Dietrich; Fabrício Figueiró; Manoella Pugliese; Maria Isabel Albano Edelweiss; Fernanda Bueno Morrone; Jean Sévigny; Ana Maria Oliveira Battastini
Journal:  Purinergic Signal       Date:  2014-01-26       Impact factor: 3.765

Review 10.  Membrane microparticles: shedding new light into cancer cell communication.

Authors:  Paloma Silva de Souza; Roberta Soares Faccion; Paula Sabbo Bernardo; Raquel Ciuvalschi Maia
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-19       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.